Abstract
Embryonic stem cell (ESC) technology should enable the generation of specific cell types for the study and treatment of human diseases. Therapeutic cloning provides a way to generate ESCs genetically matched to diseased individuals through nuclear reprogramming of the somatic genome. However, practical and ethical limitations associated with therapeutic cloning are calling for the development of oocyte- and-embryo-free alternatives for obtaining of autologous pluripotent cells for transplantation therapy. An alternative approach to reprogram the somatic genome involves fusion between somatic and pluripotent cells. Potential fusion partners with reprogrmaming activities include embryonal carcinoma cells, embryonic germ cells, and ESCs.
Experimental evidence is now available, which demonstrates that mouse and human somatic cells can be reprogrammed by fusion to form pluripotent hybrid cells. Recent progress infusion-based reprogramming is reviewed with reference to the developmenta potency of hybrid cells as well as genetic and epigenetic correlates of reprogramming. However, hybrid cells lack therapeutic potential because of their abnormal ploidy and the presence of nonautologous genes from the pluripotent parent. We discuss the potential of fusion-based reprogramming for the generation of diploid, autologous pluripotent cells using two alternative routes: the enucleation of ESCs and the fusion of such cytoplasts to somatic cell karyplasts or intact somatic cells, and the selective elimination of the pluripotent genome following fusion to the somatic partner. Finally, these approaches are discussed in the light of recent progress showing that overexpression of embryonic transcription factors can restore a state of pluripotency to somatic cells.
Similar content being viewed by others
References
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Nature 1997;385:810–813.
Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R. Nature 1998;394:369–374.
Meissner A, Jaenisch R. Dev Dyn 2006;235:2460–2469.
Kawase E, Yamazaki Y, Yagi T, Yanagimachi R, Pedersen RA. Genesis 2000;28:156–163.
Munsie MJ, Michalska AE, O'Brien CM, Trounson AO, Pera MF, Mountford PS. Curr Biol 2000;10:989–992.
Wakayama T, Tabar V, Rodriguez I, Perry AC, Studer L, Mombaerts P. Science 2001;292:740–743.
Hochedlinger K, Jaenisch R. Nature 2002;415:1035–1038.
Eggan K, Baldwin K, Tackett M, et al. Nature 2004;428:44–49.
Inoue K, Wakao H, Ogonuki N, et al. Curr Biol 2005;15:1114–1118.
Wakayama S, Mizutani E, Kishigami S, et al. J Reprod Dev 2005;51:765–772.
Hochedlinger K, Jaenisch R. Nature 2006;441:1061–1067.
Dean W, Santos F, Reik W. Semin Cell Dev Biol 2003;14:93–100.
Boiani M, Eckardt S, Scholer HR, McLaughlin KJ. Gene Dev 2002;16:1209–1219.
Bortvin A, Eggan K, Skaletsky H, et al. Development 2003; 130:1673–1680.
Rideout WM 3rd, Eggan K, Jaenisch R. Science 2001;293: 1093–1098.
Hochedlinger K, Jaenisch R. Curr Opin Cell Biol 2002;14:741–748.
Blelloch R, Wang Z, Meissner A, Pollard S, Smith A, Jaenisch R. Stem Cells 2006;Epub ahead of print.
Kishigami S, Mizutani E, Ohta H, et al. Biochem Biophys Res Commun 2006;340:183–189.
Dennis C. Nature 2006;439:652–655.
Taranger CK, Noer A, Sorensen AL, Hakelien AM, Boquest AC, Collas P. Mol Biol Cell 2005;16:5719–5735.
Meissner A, Jaenisch R. Nature 2006;439:212–215.
Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Nature 2006; 444:481–485.
Hubner K, Fuhrmann G, Christenson LK, et al. Science 2003;300:1251–1256.
Baron MH, Maniatis T. Cell 1986;46:591–602.
Blau HM, Blakely BT. Semin Cell Dev Biol 1999;10:267–272.
Miller RA, Ruddle FH. Cell 1976;9:45–55.
Miller RA, Ruddle FH. Dev Biol 1977;56:157–173.
Miller RA, Ruddle FH. Somatic Cell Genet 1977;3:247–261.
Andrews PW, Goodfellow PN. Somatic Cell Genet 1980;6:271–284.
Forejt J, Gregorova S, Dohnal K, Nosek J. Cell Differ 1984; 15:229–234.
Flasza M, Shering AF, Smith K, Andrews PW, Talley P, Johnson PA. Cloning Stem Cells 2003;5:339–354.
Hajkova P, Erhardt S, Lane N, et al. Mech Dev 2002;117:15–23.
Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. EMBO J 1997;16:6510–6520.
Rathjen J, Haines BP, Hudson KM, Nesci A, Dunn S, Rathjen PD. Development 2002;129:2649–2661.
Matveeva NM, Shilov AG, Kaftanovskaya EM et al. Mol Reprod Dev 1998;50:128–138.
Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. Curr Biol 2001;11:1553–1558.
Ying Q, Nichols J, Evans EP, Smith AG. Nature 2002;416:545–548.
Pells S, Di Domenico AI, Gallagher EJ, McWhir J. Cloning Stem Cells 2002;4:331–338.
Terada N, Hamazaki T, Oka M, et al. Nature 2002;416:542–545.
Weimann JM, Johnsson CB, Trejo A, Blau HM. Nat Cell Biol 2003;5:959–966.
Tada M, Morizane A, Kimura H, et al. Dev Dyn 2003;227:504–510.
Hatano SY, Tada M, Kimura H, et al. Mech Dev 2005;122:67–79.
Fry CJ, Peterson CL. Curr Biol 2001;11:R185-R197.
Lachner M, O'Sullivan RJ, Jenuwein T. J Cell Sci 2003; 116:2117–2124.
Kimura H, Tada M, Nakatsuji N, Tada T. Mol Cell Biol 2004; 24:5710–5720.
Cowan CA, Atienza J, Melton DA, Eggan K. Science 2005; 309:1369–1373.
Yu J, Vodyanik MA, He P, Slukvin II, Thomson JA. Stem Cells 2006;4:168–176.
Vassilopoulos G, Russell DW. Curr Opin Genet Dev 2003;13:480–485.
Matveeva NM, Pristyazhnyuk IE, Temirova SA, et al. Mol Reprod Dev 2005;71:305–314.
Bunn CL, Eisenstadt JM. Somatic Cell Genet 1977;3:335–341.
Hakelien AM, Landsverk HB, Robl JM, Skalhegg BS, Collas P. Nat Biotechnol 2002;20:460–466.
Byrne JA, Simonsson S, Western PS, Gurdon JB. Curr Biol 2003;13:1206–1213.
Do JT, Scholer HR. Stem Cells 2004;22:941–949.
Strelchenko N, Kukharenko V, Shkumatov A, Verlinsky O, Kuliev A, Verlinsky Y. Reprod Biomed Online 2006;12:107–111.
Pralong D, Mrozik K, Occhiodoro F, et al. Cloning Stem Cells 2005;7:265–271.
Pralong D, Lim ML, Vassiliev I, et al. Cloning Stem Cells 2005;7:272–278.
Blau HM, Baltimore D. J Cell Biol 1991;12:781–783.
McBurney MW. Cell 1977;12:653–662.
Do JT, Scholer HR. Reprod Fertil Dev 2005;17:143–149.
Silva J, Chambers I, Pollard S, Smith A. Nature 2006;441: 997–1001.
Takahashi K, Yamanaka S. Cell 2006;126:663–676.
Campbell KH, Loi P, Otaegui PJ, Wilmut I. Rev Reprod 1996;40–46.
Stead E, White J, Faast R, et al. Oncogene 2002;21:8320–8333.
Latham KE. Differentiation 2004;72:11–22.
Radomska HS, Eckhardt LA. J Immunol Methods 1995;188:209–217.
Yeom YI, Fuhrmann G, Ovitt CE, et al. Development 1996; 122:881–894.
Matsumura H, Tada M, Otsuji T, et al. Nat. Methods 2007;4: 23–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pralong, D., Trounson, A.O. & Verma, P.J. Cell fusion for reprogramming pluripotency. Stem Cell Rev 2, 331–340 (2006). https://doi.org/10.1007/BF02698060
Issue Date:
DOI: https://doi.org/10.1007/BF02698060